SEEGENE, INC. Logo

SEEGENE, INC.

Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.

096530 | KO

Overview

Corporate Details

ISIN(s):
KR7096530001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 오금로 91(방이동) 7층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Seegene, Inc. is a global molecular diagnostics company specializing in the development and manufacturing of in vitro diagnostic (IVD) products. The company focuses on syndromic quantitative PCR (qPCR) technologies, offering multiplex assays that can simultaneously detect multiple pathogens from a single sample. Its product portfolio includes automated systems like STARlet-AIOS™ and solutions for respiratory infections, sexually transmitted infections (STIs), and HPV screening. Through strategic collaborations with partners such as Microsoft and a technology-sharing initiative called OneSystem™, Seegene aims to standardize and increase the accessibility of molecular diagnostics for healthcare providers and research laboratories worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 17.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.1 MB
2025-08-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.4 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.3 KB
2025-08-06 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 31.3 KB
2025-08-01 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.0 KB
2025-06-11 00:00
Transaction in Own Shares
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean 79.7 KB
2025-06-09 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 17.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-05-07 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.4 KB
2025-05-07 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.3 KB
2025-05-07 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 31.4 KB
2025-05-02 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.0 KB

Automate Your Workflow. Get a real-time feed of all SEEGENE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEEGENE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEEGENE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Kyivmedpreparat Logo
A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.
Ukraine
KMED
KYONGBO PHARMACEUTICAL CO., LTD. Logo
Manufactures APIs and finished drugs, offering global CDMO services from development to production.
South Korea
214390
KYORIN Pharmaceutical Co., Ltd. Logo
Researches, develops, and sells a portfolio of ethical, generic, and OTC medicines.
Japan
4569
Kyowa Kirin Co.,Ltd. Logo
Develops antibody medicines for oncology, nephrology, immunology, and allergy.
Japan
4151
KyungdongPharm Logo
Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.
South Korea
011040
KYUNG NAM PHARM.CO.,LTD. Logo
South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.
South Korea
053950
Kyverna Therapeutics, Inc. Logo
Developing CAR T-cell therapies for durable remission in autoimmune diseases.
United States of America
KYTX
Labiana S.A. Logo
Pharmaceutical CDMO for animal & human health with its own line of vaccines and generics.
Spain
LAB
Labocanna Spolka Akcyjna Logo
Cultivates and distributes medical marijuana and cannabinoid products for clinical and consumer use.
Poland
LCN
Labomar Logo
A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.
Italy
LBM

Talk to a Data Expert

Have a question? We'll get back to you promptly.